☰

Kenneth L. van Golen - Publications

Affiliations: 
Department of Biological Sciences University of Delaware, Newark, DE, United States 
Area:
Molecular Biology, General Biophysics
Tree Info Similar researchers PubMed Report error

45 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Pradhan L, Moore D, Ovadia EM, Swedzinski SL, Cossette T, Sikes RA, van Golen K, Kloxin AM. Dynamic bioinspired coculture model for probing ER breast cancer dormancy in the bone marrow niche. Science Advances. 9: eade3186. PMID 36888709 DOI: 10.1126/sciadv.ade3186  0.544
2022 Rypens C, Bertucci F, Finetti P, Robertson F, Fernandez SV, Ueno N, Woodward WA, Van Golen K, Vermeulen P, Dirix L, Viens P, Birnbaum D, Devi GR, Cristofanilli M, Van Laere S. Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC. Npj Breast Cancer. 8: 12. PMID 35042871 DOI: 10.1038/s41523-021-00379-6  0.384
2020 Ovadia EM, Pradhan L, Sawicki LA, Cowart JE, Huber RE, Polson SW, Chen C, van Golen KL, Ross KE, Wu CH, Kloxin AM. Understanding ER+ Breast Cancer Dormancy Using Bioinspired Synthetic Matrices for Long-Term 3D Culture and Insights into Late Recurrence. Advanced Biosystems. e2000119. PMID 32603024 DOI: 10.1002/adbi.202000119  0.537
2017 Woodward WA, Cristofanilli M, Merajver SD, Van Laere S, Pusztai L, Bertucci F, Berditchevski F, Polyak K, Overmoyer B, Devi GR, Sterneck E, Schneider R, Debeb BG, Wang X, van Golen KL, et al. Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10 Anniversary Conference. Journal of Cancer. 8: 3607-3614. PMID 29667990 DOI: 10.7150/Jca.21200  0.339
2017 Joglekar-Javadekar M, Van Laere S, Bourne M, Moalwi M, Finetti P, Vermeulen PB, Birnbaum D, Dirix LY, Ueno N, Carter M, Rains J, Ramachandran A, Bertucci F, van Golen KL. Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC). Neoplasia (New York, N.Y.). 19: 564-573. PMID 28609680 DOI: 10.1016/J.Neo.2017.03.002  0.604
2017 Joglekar M, Elbazanti WO, Weitzman MD, Lehman HL, van Golen KL. Caveolin-1 Mediates Inflammatory Breast Cancer Cell Invasion via the Akt1 Pathway and RhoC GTPase. Journal of Cellular Biochemistry. 118: 1273. PMID 28316145 DOI: 10.1002/Jcb.25876  0.815
2015 Joglekar M, Elbazanti WO, Weitzman MD, Lehman HL, van Golen KL. Caveolin-1 mediates inflammatory breast cancer cell invasion via the Akt1 pathway and RhoC GTPase. Journal of Cellular Biochemistry. 116: 923-33. PMID 25559359 DOI: 10.1002/Jcb.25025  0.815
2013 van Golen KL, Cristofanilli M. The Third International Inflammatory Breast Cancer Conference. Breast Cancer Research : Bcr. 15: 318. PMID 24188125 DOI: 10.1186/bcr3571  0.573
2013 Lehman HL, Dashner EJ, Lucey M, Vermeulen P, Dirix L, Van Laere S, van Golen KL. Modeling and characterization of inflammatory breast cancer emboli grown in vitro. International Journal of Cancer. 132: 2283-94. PMID 23129218 DOI: 10.1002/Ijc.27928  0.678
2013 Schaefer RJ, Bonor JC, Joglekar MS, Van Golen KL, Nohe AG. 1, 25 Dihydroxyvitamin D3 uptake is localized at caveolae and requires caveolar function Journal of Biomedical Nanotechnology. 9: 1707-1715. DOI: 10.1166/jbn.2013.1662  0.396
2012 Martin BJ, van Golen KL. A comparison of cholesterol uptake and storage in inflammatory and noninflammatory breast cancer cells. International Journal of Breast Cancer. 2012: 412581. PMID 23346407 DOI: 10.1155/2012/412581  0.524
2012 Gurski LA, Xu X, Labrada LN, Nguyen NT, Xiao L, van Golen KL, Jia X, Farach-Carson MC. Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogels. Plos One. 7: e50075. PMID 23166824 DOI: 10.1371/Journal.Pone.0050075  0.39
2012 Lehman HL, Van Laere SJ, van Golen CM, Vermeulen PB, Dirix LY, van Golen KL. Regulation of inflammatory breast cancer cell invasion through Akt1/PKBα phosphorylation of RhoC GTPase. Molecular Cancer Research : McR. 10: 1306-18. PMID 22896661 DOI: 10.1158/1541-7786.Mcr-12-0173  0.806
2012 Hillyer RL, Sirinvasin P, Joglekar M, Sikes RA, van Golen KL, Nohe A. Differential effects of vitamin D treatment on inflammatory and non-inflammatory breast cancer cell lines. Clinical & Experimental Metastasis. 29: 971-9. PMID 22610818 DOI: 10.1007/S10585-012-9486-0  0.547
2011 Chaterjee M, van Golen KL. Breast cancer stem cells survive periods of farnesyl-transferase inhibitor-induced dormancy by undergoing autophagy. Bone Marrow Research. 2011: 362938. PMID 22046561 DOI: 10.1155/2011/362938  0.526
2011 Chatterjee M, Sequeira L, Jenkins-Kabaila M, Dubyk CW, Pathak S, van Golen KL. Individual rac GTPases mediate aspects of prostate cancer cell and bone marrow endothelial cell interactions. Journal of Signal Transduction. 2011: 541851. PMID 21776386 DOI: 10.1155/2011/541851  0.724
2011 Chatterjee M, van Golen KL. Farnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and RhoC GTPase activity and induces a dormant phenotype. International Journal of Cancer. Journal International Du Cancer. 129: 61-9. PMID 20824700 DOI: 10.1002/Ijc.25655  0.808
2010 Vermeulen PB, van Golen KL, Dirix LY. Angiogenesis, lymphangiogenesis, growth pattern, and tumor emboli in inflammatory breast cancer: a review of the current knowledge. Cancer. 116: 2748-54. PMID 20503405 DOI: 10.1002/Cncr.25169  0.481
2008 Hall CL, Dubyk CW, Riesenberger TA, Shein D, Keller ET, van Golen KL. Type I collagen receptor (alpha2beta1) signaling promotes prostate cancer invasion through RhoC GTPase. Neoplasia (New York, N.Y.). 10: 797-803. PMID 18670640 DOI: 10.1593/Neo.08380  0.342
2008 van Golen KL, Ying C, Sequeira L, Dubyk CW, Reisenberger T, Chinnaiyan AM, Pienta KJ, Loberg RD. CCL2 induces prostate cancer transendothelial cell migration via activation of the small GTPase Rac. Journal of Cellular Biochemistry. 104: 1587-97. PMID 18646053 DOI: 10.1002/Jcb.21652  0.39
2008 Cooper CR, Graves B, Pruitt F, Chaib H, Lynch JE, Cox AK, Sequeria L, van Golen KL, Evans A, Czymmek K, Bullard RS, Donald CD, Sol-Church K, Gendernalik JD, Weksler B, et al. Novel surface expression of reticulocalbin 1 on bone endothelial cells and human prostate cancer cells is regulated by TNF-alpha. Journal of Cellular Biochemistry. 104: 2298-309. PMID 18561328 DOI: 10.1002/Jcb.21785  0.334
2008 Sequeira L, Dubyk CW, Riesenberger TA, Cooper CR, van Golen KL. Rho GTPases in PC-3 prostate cancer cell morphology, invasion and tumor cell diapedesis. Clinical & Experimental Metastasis. 25: 569-79. PMID 18461284 DOI: 10.1007/s10585-008-9173-3  0.458
2008 Miles FL, Pruitt FL, van Golen KL, Cooper CR. Stepping out of the flow: capillary extravasation in cancer metastasis. Clinical & Experimental Metastasis. 25: 305-24. PMID 17906932 DOI: 10.1007/S10585-007-9098-2  0.509
2006 van Golen KL. Is caveolin-1 a viable therapeutic target to reduce cancer metastasis? Expert Opinion On Therapeutic Targets. 10: 709-21. PMID 16981828 DOI: 10.1517/14728222.10.5.709  0.381
2006 Hall CL, Dai J, van Golen KL, Keller ET, Long MW. Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone. Cancer Research. 66: 8648-54. PMID 16951179 DOI: 10.1158/0008-5472.Can-06-1544  0.381
2006 Zhang L, Chenwei L, Mahmood R, van Golen K, Greenson J, Li G, D'Silva NJ, Li X, Burant CF, Logsdon CD, Simeone DM. Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer. Cancer Research. 66: 898-906. PMID 16424023 DOI: 10.1158/0008-5472.Can-05-3025  0.407
2006 Yao H, Dashner EJ, van Golen CM, van Golen KL. RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility. Oncogene. 25: 2285-96. PMID 16314838 DOI: 10.1038/sj.onc.1209260  0.686
2006 Van Laere SJ, Van den Eynden GG, Van der Auwera I, Vandenberghe M, van Dam P, Van Marck EA, van Golen KL, Vermeulen PB, Dirix LY. Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling. Breast Cancer Research and Treatment. 95: 243-55. PMID 16261404 DOI: 10.1007/S10549-005-9015-9  0.464
2006 Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Breast Cancer Research and Treatment. 95: 219-28. PMID 16244790 DOI: 10.1007/S10549-005-9002-1  0.625
2005 Radunsky GS, van Golen KL. The current understanding of the molecular determinants of inflammatory breast cancer metastasis. Clinical & Experimental Metastasis. 22: 615-20. PMID 16642401 DOI: 10.1007/s10585-006-9000-7  0.609
2005 Zhang X, Lin M, van Golen KL, Yoshioka K, Itoh K, Yee D. Multiple signaling pathways are activated during insulin-like growth factor-I (IGF-I) stimulated breast cancer cell migration. Breast Cancer Research and Treatment. 93: 159-68. PMID 16187236 DOI: 10.1007/S10549-005-4626-8  0.388
2005 Kleer CG, Griffith KA, Sabel MS, Gallagher G, van Golen KL, Wu ZF, Merajver SD. RhoC-GTPase is a novel tissue biomarker associated with biologically aggressive carcinomas of the breast. Breast Cancer Research and Treatment. 93: 101-10. PMID 16187229 DOI: 10.1007/S10549-005-4170-6  0.603
2005 Arumugam T, Simeone DM, Van Golen K, Logsdon CD. S100P promotes pancreatic cancer growth, survival, and invasion. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 5356-64. PMID 16061848 DOI: 10.1158/1078-0432.CCR-05-0092  0.353
2005 Lin M, DiVito MM, Merajver SD, Boyanapalli M, van Golen KL. Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1. Molecular Cancer. 4: 21. PMID 15969750 DOI: 10.1186/1476-4598-4-21  0.439
2004 Lin M, van Golen KL. Rho-regulatory proteins in breast cancer cell motility and invasion. Breast Cancer Research and Treatment. 84: 49-60. PMID 14999154 DOI: 10.1023/B:BREA.0000018424.43445.f3  0.589
2003 van Golen KL. Inflammatory breast cancer: relationship between growth factor signaling and motility in aggressive cancers. Breast Cancer Research : Bcr. 5: 174-9. PMID 12793901 DOI: 10.1186/bcr598  0.501
2002 van Golen KL, Bao L, DiVito MM, Wu Z, Prendergast GC, Merajver SD. Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor. Molecular Cancer Therapeutics. 1: 575-83. PMID 12479217  0.552
2002 Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, De Carvalho M, Mesri EA, Robins DM, Dick RD, Brewer GJ, Merajver SD. Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. Cancer Research. 62: 4854-9. PMID 12208730  0.405
2002 van Golen KL, Bao L, Brewer GJ, Pienta KJ, Kamradt JM, Livant DL, Merajver SD. Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma. Neoplasia (New York, N.Y.). 4: 373-9. PMID 12192595 DOI: 10.1038/Sj.Neo.7900258  0.309
2002 Kleer CG, Tseng MD, Gutsch DE, Rochford RA, Wu Z, Joynt LK, Helvie MA, Chang T, Van Golen KL, Merajver SD. Detection of Epstein-Barr virus in rapidly growing fibroadenomas of the breast in immunosuppressed hosts. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 15: 759-64. PMID 12118114 DOI: 10.1038/Modpathol.3880602  0.443
2002 van Golen KL, Bao LW, Pan Q, Miller FR, Wu ZF, Merajver SD. Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer. Clinical & Experimental Metastasis. 19: 301-11. PMID 12090470 DOI: 10.1023/A:1015518114931  0.547
2002 Kleer CG, Zhang Y, Pan Q, van Golen KL, Wu ZF, Livant D, Merajver SD. WISP3 is a novel tumor suppressor gene of inflammatory breast cancer. Oncogene. 21: 3172-80. PMID 12082632 DOI: 10.1038/Sj.Onc.1205462  0.517
2002 Kleer CG, van Golen KL, Zhang Y, Wu ZF, Rubin MA, Merajver SD. Characterization of RhoC expression in benign and malignant breast disease: a potential new marker for small breast carcinomas with metastatic ability. The American Journal of Pathology. 160: 579-84. PMID 11839578 DOI: 10.1016/S0002-9440(10)64877-8  0.533
2000 Kleer CG, van Golen KL, Merajver SD. Molecular biology of breast cancer metastasis. Inflammatory breast cancer: Clinical syndrome and molecular determinants Breast Cancer Research. 2: 423-429. PMID 11250736 DOI: 10.1186/Bcr89  0.594
2000 Van Golen KL, Wu ZF, Qiao XT, Bao LW, Merajver SD. RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells Neoplasia. 2: 418-425. PMID 11191108 DOI: 10.1038/Sj.Neo.7900115  0.526
Show low-probability matches.